ARCHIVES

CCIRC Okays New Effort To Rate Disease Committees, Modalities In Groups, Effective with Next Round

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

Phase II Study: Proton Therapy Can Have Similar Success Rate, Smaller Level of Risk in Treatment of Hodgkin Lymphoma

July 25, 2014

In Brief: Schweitzer ACS President, Dodd President Elect, FDA Commissioner Resigns Abruptly

November 17, 1989

New Jersey Legislature Votes to Oppose USPSTF PSA Screening Downgrade

January 20, 2012

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004